Squeeze Me: DRUGThis one is for Roaring Kitty :)
I do not have a crystal ball
But what I do have is enough
Trade What You See..Not What You Hope For
Long
Bright Minds Biosciences Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.97 USD
−8.78 M USD
0.00 USD
7.34 M
About Bright Minds Biosciences Inc.
Sector
Industry
CEO
Ian B. McDonald
Website
Headquarters
Chicago
Founded
2019
IPO date
Nov 8, 2021
Identifiers
3
ISIN CA10919W4056
Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in Chicago, IL.
Related stocks
Long
DRUG - +100% potential 1:5 RR play Nice growth stock and I really like the consolidation it's gone through which gives me confidence of a breakout above.
The Analyst rate it highly and it could be a 1:5 RR which is excellent odds on money.
Long
DRUG (Bright Minds Biosciences Inc.): Massive 2,000% Surge!DRUG (Bright Minds Biosciences Inc.) Super Move Captured with Risological Swing Trader
We entered a long position on 14th October at 1.23 using the daily time frame, catching this explosive upward movement with the precision of the Risological Swing Trader. The indicator identified the perfect entr
Long
Penny stocks 2022Penny stocks are literally down to pennies per share now. Maybe 1 out of 10 of these companies may actually be successful in the future. As for now, none of them are a good investment.
WKHS
BBIG
MMAT
SNDL
PHUN
OCGN
DRUG
BKKT
WISH
MULN
Do your own due diligence, your risk is 100% your responsibilit
DRUG | Divergence Forming | WatchingBright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain
Long
Long
$DRUG Next Target PTs 4.50-9 and higherBright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain
Long
Ceo is accumulating in this range Drug is an interesting psychedelic play that aims to to be a next generation psychedelic company.
Currently we are going sideways and it has some bullish factors goin for it
TA bullish factors
1) it broke the downward trendline and had a successful retest
2) we can see the macd starting to pinch and
Long
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
490330
SAMSUNGACTIVE KoAct US Alzheimer's & CNS Therapeutics Active ETF UnitsWeight
1.76%
Market value
67.21 K
USD
Explore more ETFs
Frequently Asked Questions
The current price of DRUG is 77.90 USD — it has decreased by −3.31% in the past 24 hours. Watch Bright Minds Biosciences Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Bright Minds Biosciences Inc. stocks are traded under the ticker DRUG.
DRUG stock has risen by 4.16% compared to the previous week, the month change is a −13.44% fall, over the last year Bright Minds Biosciences Inc. has showed a 72.46% increase.
We've gathered analysts' opinions on Bright Minds Biosciences Inc. future price: according to them, DRUG price has a max estimate of 191.71 USD and a min estimate of 80.33 USD. Watch DRUG chart and read a more detailed Bright Minds Biosciences Inc. stock forecast: see what analysts think of Bright Minds Biosciences Inc. and suggest that you do with its stocks.
DRUG reached its all-time high on Jan 6, 2026 with the price of 123.75 USD, and its all-time low was 0.93 USD and was reached on Apr 30, 2024. View more price dynamics on DRUG chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DRUG stock is 11.68% volatile and has beta coefficient of 2.09. Track Bright Minds Biosciences Inc. stock price on the chart and check out the list of the most volatile stocks — is Bright Minds Biosciences Inc. there?
Today Bright Minds Biosciences Inc. has the market capitalization of 776.63 M, it has decreased by −2.32% over the last week.
Yes, you can track Bright Minds Biosciences Inc. financials in yearly and quarterly reports right on TradingView.
Bright Minds Biosciences Inc. is going to release the next earnings report on May 14, 2026. Keep track of upcoming events with our Earnings Calendar.
DRUG net income for the last quarter is −5.51 M USD, while the quarter before that showed −2.93 M USD of net income which accounts for −87.80% change. Track more Bright Minds Biosciences Inc. financial stats to get the full picture.
No, DRUG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DRUG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bright Minds Biosciences Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bright Minds Biosciences Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bright Minds Biosciences Inc. stock shows the buy signal. See more of Bright Minds Biosciences Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.